Oragenics Provides Update on SARS-CoV-2 (COVID-19) Program
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, provided an update on progress with its SARS-CoV-2 (COVID-19) vaccine candidate and announced the termination of its clinical development program with AG013 for the treatment of severe oral […]
Ology Bioservices Wins Three Department of Defense Awards Totaling More Than $16 Million
UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced that the Department of Defense (DOD), through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA), has awarded the company with three biomanufacturing contracts with a combined value of […]
AGTC Boosts AAV Manufacturing Productivity With Herpes Simplex Virus
By using the herpes simplex virus (HSV) as a helper for its adeno-associated viral (AAV) platform UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC) created AAVs that are more robust, purer and lower cost than any of the other methods. Its gene therapy program for X-linked retinitis pigmentosa […]
Axogen Announces New Seven-Year Financing Agreement With Oberland Capital
UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced a financing agreement with Oberland Capital and provided preliminary, estimated revenue for the second quarter ended June 30, 2020. The financing agreement provides up to $75 million in […]
UF’s Sid Martin Biotech Named Top Global Incubator for Record Third Time
For the third time, the International Business Innovation Association (InBIA) has awarded its highest honor – the Randall M. Whaley Incubator of the Year award – to UF Innovate | Sid Martin Biotech. “Being named the best incubator on the planet is amazing. Receiving this award three times in a decade speaks volumes to the […]
Department of Defense Awards Ology Bioservices Contract to Advance Anti-Botulinum Neurotoxin Monoclonal Antibodies
UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced it has been awarded a contract to advance the development of a cocktail of anti-botulinum neurotoxin monoclonal antibodies (mAb) by the Department of Defense (DOD) through the Joint Science and Technology Office of […]
How to Create a COVID-19 Vaccine
Alan Joslyn Ph.D. president and CEO of UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, speaks with James Di Virgilio, Radio Cade podcast co-host, about COVID-19 vaccine challenges and explore Oragenics journey from idea generation to COVID-19 […]
UF Ranked No. 1 Nationally in Innovation Impact
The University of Florida is the most productive large university in the country at leveraging its research funding into new companies, new jobs and new ideas, according to a report released last week by the George W. Bush Institute and the Opus Faveo Innovation Development consulting firm. A team of economists and business development experts […]
AGTC Announces Significant Productivity and Quality Enhancement to Its Proprietary Manufacturing Process
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, provided an update on the continued productivity and quality improvements made in its proprietary manufacturing platform that is currently being used […]
Morphogenesis Seeks Skin Cancer Patients for New Clinical Trials
Known for developing personalized immunotherapies for the treatment of cancer through novel cell and gene therapies, UF startup and UF Innovate | Sid Martin Biotech alumni company Morphogenesis, Inc., has received FDA approval to expand its human clinical trials into two more types of cancer. Using its ImmuneFx (IFx) cancer vaccine technology that initiates the power […]